ANIX Anixa Biosciences, Inc.

Fundamentals / CIK 0000715446 / USD

Anixa Biosciences, Inc. reported $15.07M in total assets and a net loss of $10.38M through October 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ANIX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$2.57M$1.29M$0-$13.18MFY 2016 Revenue: $300KFY 2016 Net Income: -$5.02M2016FY 2017 Revenue: $362KFY 2017 Net Income: -$5.01M2017FY 2018 Revenue: $1.11MFY 2018 Net Income: -$14.00M2018FY 2019 Revenue: $250KFY 2019 Net Income: -$11.65M2019FY 2020 Net Income: -$10.02M2020FY 2021 Revenue: $512KFY 2021 Net Income: -$12.95M2021FY 2022 Net Income: -$13.60M2022FY 2023 Revenue: $210KFY 2023 Net Income: -$9.81M2023FY 2024 Revenue: $210KFY 2024 Net Income: -$12.55M2024FY 2025 Net Income: -$10.93M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31
Revenue -- $210K $210K -- $512K -- $250K $1.11M $362K $300K
Research & Development $5.07M $6.40M $4.77M $6.70M $6.19M $4.38M $5.47M $6.81M $1.60M $1.56M
Selling, General & Admin -- -- -- -- -- -- $5.66M $6.91M $4.41M $2.71M
Operating Income -$11.70M -$13.83M -$11.01M -$13.88M -$13.14M -$9.98M -$11.89M -$14.29M -$6.08M -$4.51M
EBITDA -- -- -- -- -- -$9.94M -$11.42M -$14.27M -$6.03M -$4.48M
Interest Income $673K $1.13M $1.08M $104K $2.0K $34K $71K $46K $19K $13K
Interest Expense -- -- -- -- -- -- -- -- $500K $520K
Income Before Tax -- -- -- -- -- -- -$11.82M -$14.24M -$5.01M -$5.02M
Net Income -$10.93M -$12.55M -$9.81M -$13.60M -$12.95M -$10.02M -$11.65M -$14.00M -$5.01M -$5.02M
Basic EPS -$0.34 -$0.39 -$0.32 $0.45 -$0.45 -$0.45 -$0.59 -$0.79 -$0.58 -$0.57
Diluted EPS -$0.34 -$0.39 -$0.32 $0.45 -$0.45 -$0.45 -$0.59 -$0.79 -$0.58 -$0.57
Basic Shares Outstanding 32.5K 31.9K 31.0K 30.4K 28.6M 22.2M 19.8M 17.6M 12.2M 8.7M
Diluted Shares Outstanding 32.5K 31.9K 31.0K 30.4K 28.6M 22.2M 19.8M 17.6M 12.2M 8.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Research & Development $1.33M $1.26M $1.10M $1.14M $1.05M $1.32M $1.55M $1.48M
Operating Income -$2.74M -$2.65M -$2.72M -$2.88M -$2.44M -$3.00M -$3.39M -$3.16M
Interest Income $112K $111K $131K $154K $156K $190K $173K $250K
Net Income -$2.61M -$2.52M -$2.56M -$2.69M -$2.26M -$2.79M -$3.18M -$2.88M
Basic EPS -$0.08 -$0.07 -$0.08 -- -$0.07 -$0.09 -$0.10 --
Diluted EPS -$0.08 -$0.07 -$0.08 -- -$0.07 -$0.09 -$0.10 --
Basic Shares Outstanding 34.2M 33.6M 33.2M -- 32.5M 32.2M 32.2M --
Diluted Shares Outstanding 34.2M 33.6M 33.2M -- 32.5M 32.2M 32.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31
Cash & Cash Equivalents $1.24M $1.27M $915K $12.36M $29.13M $6.42M $3.49M $3.06M $3.34M $2.49M
Short-Term Investments $13.93M $18.65M $22.93M $17.33M $6.60M $2.64M $2.35M $2.00M $3.50M $750K
Cash & Short-Term Investments $15.17M $19.92M $23.84M $29.69M $35.73M $9.06M $5.84M $5.06M $6.84M $3.24M
Accounts Receivable, Net -- $173K $270K $46K -- $2.2K $67K $307K -- --
Total Current Assets $15.89M $21.36M $25.36M $30.20M $36.00M $9.37M $6.09M $5.54M $7.01M $3.40M
Property, Plant & Equipment, Net -- -- -- -- -- -- $201K $73K $53K $157K
Total Non-Current Assets $193K $229K $166K $212K $254K $84K $201K $910K $1.80M $2.23M
Total Assets $16.08M $21.59M $25.52M $30.41M $36.26M $9.45M $6.29M $6.45M $8.81M $5.63M
Accounts Payable $165K $525K $206K $265K $136K $232K $586K $582K $480K $373K
Total Current Liabilities $1.97M $2.50M $2.03M $2.04M $1.27M $1.19M $1.48M $1.27M $889K $469K
Total Non-Current Liabilities $163K $203K $123K $175K $220K $0 $0 $0 $0 $4.17M
Total Liabilities $2.13M $2.70M $2.15M $2.21M $1.49M $1.19M $1.48M $1.27M $889K $4.64M
Total Debt (incl. Leases) $204K $232K $175K $221K $259K $55K -- -- -- --
Common Stock $330K $322K $311K $309K $301K $242K $203K $189K $166K $88K
Retained Earnings -$251.7M -$240.8M -$228.2M -$218.4M -$204.8M -$191.8M -$181.8M -$170.2M -$156.2M -$151.2M
Total Stockholders' Equity $15.16M $20.00M $24.34M $29.05M $35.44M $8.76M $5.24M $5.43M $7.92M $987K
Total Equity $13.95M $18.89M $23.37M $28.20M $34.77M $8.26M $4.81M $5.18M $7.92M $987K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Cash & Cash Equivalents $1.40M $1.48M $1.55M $1.24M $1.50M $1.91M $1.05M $1.27M
Short-Term Investments $12.47M $12.21M $12.65M $13.93M $14.53M $13.69M $16.20M $18.65M
Cash & Short-Term Investments $13.86M $13.69M $14.20M $15.17M $16.03M $15.60M $17.25M $19.92M
Accounts Receivable, Net -- $56K -- -- -- -- -- $173K
Total Current Assets $14.91M $14.69M $15.05M $15.89M $17.45M $16.77M $18.69M $21.36M
Total Non-Current Assets $163K $173K $183K $193K $202K $211K $220K $229K
Total Assets $15.07M $14.87M $15.23M $16.08M $17.65M $16.98M $18.91M $21.59M
Accounts Payable $282K $252K $148K $165K $276K $284K $600K $525K
Total Current Liabilities $1.75M $1.50M $1.24M $1.97M $2.07M $1.89M $2.00M $2.50M
Total Non-Current Liabilities $128K $140K $151K $163K $174K $184K $194K $203K
Total Liabilities $1.87M $1.64M $1.39M $2.13M $2.24M $2.07M $2.19M $2.70M
Total Debt (incl. Leases) $174K $184K $193K $204K $213K $221K $230K $232K
Common Stock $346K $339K $335K $330K $328K $322K $322K $322K
Retained Earnings -$259.4M -$256.8M -$254.2M -$251.7M -$249.0M -$246.7M -$243.9M -$240.8M
Total Stockholders' Equity $14.47M $14.47M $15.08M $15.16M $16.59M $16.07M $17.85M $20.00M
Total Equity $13.20M $13.22M $13.85M $13.95M $15.41M $14.91M $16.71M $18.89M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31
Net Income -$11.03M -$12.70M -$9.93M -$13.77M -$13.13M -$10.09M -$11.82M -$14.24M -$5.01M -$5.02M
Depreciation & Amortization -- -- -- -- -- $38K $466K $18K $43K $33K
Stock-Based Compensation $3.68M $4.42M $4.42M $6.00M $7.50M $3.92M -$5.71M -$8.90M -$1.68M --
Change in Receivables $173K $97K -$224K -$29K -- $64K $272K -$259K -- --
Change in Payables -$360K $319K -$59K $129K -$96K -$353K $3.8K $102K $107K -$1.5K
Operating Cash Flow -$7.17M -$7.33M -$6.21M -$6.49M -$4.94M -$6.18M -$4.74M -$4.27M -$3.80M -$3.38M
Capital Expenditure -- -- -- -- -- -$16K -$175K -$38K -$30K -$147K
Free Cash Flow -- -- -- -- -- -$6.19M -$4.92M -$4.31M -$3.83M -$3.53M
Investing Cash Flow $4.87M $4.28M -$5.60M -$10.73M -$3.92M -$306K -$525K $1.46M -$2.74M $1.50M
Common Stock Issued $2.38M $2.96M -- -- $10.83M $9.27M $5.53M $2.47M $3.46M --
Share Repurchases -- -$6.0K -- -- -- -- -- -- -- --
Financing Cash Flow $2.28M $3.42M $366K $452K $31.57M $9.41M $5.70M $2.53M $7.38M -$2.7K
Net Change in Cash -$27K $356K -$11.45M -$16.77M $22.71M $2.93M $436K -$283K $851K -$1.88M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Net Income -$2.62M -$2.54M -$2.58M -$2.72M -$2.28M -$2.81M -$3.21M -$2.91M
Stock-Based Compensation $637K $637K $768K $859K $829K $962K $1.03M $980K
Change in Receivables -- -- -- $0 $0 $0 $173K $237K
Change in Payables $30K $104K -$17K -$111K -$8.0K -$316K $75K $223K
Operating Cash Flow -$1.77M -$1.74M -$2.61M -$1.25M -$1.51M -$1.50M -$2.90M -$927K
Investing Cash Flow -$245K $422K $1.23M $654K -$833K $2.34M $2.70M $867K
Common Stock Issued -- -- -- $454K $1.93M $14K -$17K -$29K
Financing Cash Flow $1.94M $1.25M $1.69M $350K $1.93M $18K -$17K $106K
Net Change in Cash -$79K -$70K $303K -$251K -$415K $857K -$218K $46K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31
Operating Margin -- -6586.2% -5243.3% -- -2565.6% -- -4756.0% -1284.4% -1676.0% -1503.0%
Net Profit Margin -- -5978.1% -4671.9% -- -2530.1% -- -4658.8% -1258.1% -1381.8% -1672.1%
Return on Equity (ROE) -72.1% -62.8% -40.3% -46.8% -36.6% -114.3% -222.5% -257.5% -63.2% -508.0%
Return on Assets (ROA) -68.0% -58.1% -38.4% -44.7% -35.7% -106.0% -185.1% -217.0% -56.8% -89.1%
Current Ratio 8.08x 8.54x 12.50x 14.83x 28.35x 7.88x 4.11x 4.38x 7.89x 7.25x
Quick Ratio 7.71x 8.04x 11.89x 14.60x 28.13x 7.62x 3.99x 4.24x 7.69x 6.91x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x -- -- -- --
Revenue Growth (YoY) -- 0.0% -- -- -- -- -77.5% +206.9% +20.8% -96.8%
EPS Growth (YoY) -- -- -171.1% -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -- -- -348.0%
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -- -- -- -369.6%
5Y Revenue / Share Growth -- +52014.3% +10638.7% -- -47.8% -- -97.0% +3092.2% +470.1% +471.0%
10Y Revenue / Share Growth -- +1463.8% +342700.0% -- +198.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Return on Equity (ROE) -71.7% -69.3% -68.4% -72.1% -67.0% -75.5% -69.9% -62.8%
Return on Assets (ROA) -68.9% -67.5% -67.7% -68.0% -63.0% -71.5% -66.0% -58.1%
Current Ratio 8.54x 9.79x 12.18x 8.08x 8.45x 8.89x 9.35x 8.54x
Quick Ratio 7.94x 9.16x 11.49x 7.71x 7.76x 8.27x 8.63x 8.04x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0000715446) · from October 31, 2010 Data through July 31, 2026 · synced Nov 20, 2026, 05:49 UTC · Open in terminal